News
Challenges And Solutions In Mental Health Medication Management
Mental health is a critical component of overall well-being, yet it is often enveloped in complexity and misunderstanding. One of the vital aspects of ensuring effective treatment for mental health conditions is the management of medication. Â
Proper medication management can...
IT & Data Management
Laboratory Data Gives Better Outcomes With Data Intelligence
With the advancement when it comes to automation and new drug modalities, modern labs happen to generate more data than ever; however, turning data into intelligence is indeed another story. Lab leaders stress on making the data actionable or...
Clinical Trials
Therapeutic Market Eyeing Better Access With Digi Innovation
Right from finding potential active substances as well as identifying novel targets to simulating how drugs will perform within the human body and also optimizing laboratory workflows, digital technologies are creating a massive impact when it comes to drug...
News
Formulation of CAR-T Cell Product Guidelines By The FDA
The FDA has gone on to publish its final guidance on January 30, 2024, that goes on to offer consideration for the development of chimeric antigen receptor- CAR T-cell products. As per the FDA, CAR T-cell products happen to...
News
African Medicines Agency To Set Up With Assistance of EMA
The European Medicines Agency- EMA went on to announce on January 26, 2024, that the European Commission-EC has gone ahead and given the agency a €10 million grant in order to support regulatory systems at both the national as...
News
How health economic models can inform resource allocation and prioritization in healthcare
Health care tends to have limited resources, such as medical personnel, drugs, equipment, and funding. Therefore, decision makers are always faced with the problem of prioritization. Prioritization helps to equitably allocate resources to provide the greatest benefit to society...
News
Biovian and 3P Biopharmaceuticals Combine to Form 3PBIOVIAN
Biovian and 3P Biopharmaceuticals, two leading biologics Contract Development and Manufacturing Organizations (CDMOs), announced their combination to establish a new pan-European leader in their field.
Backed by their common shareholder, Keensight Capital, one of the leading private equity funds dedicated...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.